Australian New Zealand Clinical Trials Registry
The Australian Particle Therapy Clinical Quality Registry – ASPIRE is registered with the Australian New Zealand Clinical Trials Registry (ANZCTR). The ANZCTR is recognised as an international committee of Medical Journal Editors acceptable registry and a Primary Registry in the World Health Organisation (WHO) registry network.
Additional information on the Australian Particle Therapy Clinical Quality Registry – ASPIRE can be found on the following link➡️ ANZCTR – Registration
TROG Cancer Research
Trans-Tasman Radiation Oncology Group – TROG Cancer Research, is dedicated to improving the way radiation therapy is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
TROG Cancer Research are proud collaborators of the Australian Bragg Centre for Cancer Research and have endorsed the Australian Particle Therapy Clinical Quality Registry – ASPIRE.
Learn more about the great work being done by TROG Cancer Research on their website ➡️ https://trog.com.au/